These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24605810)

  • 1. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.
    Wimo A; Ballard C; Brayne C; Gauthier S; Handels R; Jones RW; Jonsson L; Khachaturian AS; Kramberger M
    J Intern Med; 2014 Mar; 275(3):304-16. PubMed ID: 24605810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia.
    Katona C; Livingston G; Cooper C; Ames D; Brodaty H; Chiu E
    Int Psychogeriatr; 2007 Jun; 19(3):345-54. PubMed ID: 17386120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Gustavsson A; Green C; Jones RW; Förstl H; Simsek D; de Reydet de Vulpillieres F; Luthman S; Adlard N; Bhattacharyya S; Wimo A
    Alzheimers Dement; 2017 Mar; 13(3):312-321. PubMed ID: 28063281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    Wimo A; Handels R; Winblad B; Black CM; Johansson G; Salomonsson S; Eriksdotter M; Khandker RK
    J Alzheimers Dis; 2020; 75(3):891-902. PubMed ID: 32390617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2012 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2012; 8(2):131-68. PubMed ID: 22404854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing health economic outcome in Alzheimer's disease clinical trials.
    Jonsson L
    J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic literature review of methodologies and data sources of existing economic models across the full spectrum of Alzheimer's disease and dementia from apparently healthy through disease progression to end of life care: a systematic review protocol.
    Karagiannidou M; Wittenberg R; Landeiro FIT; Park AL; Fry A; Knapp M; Gray AM; Tockhorn-Heidenreich A; Castro Sanchez AY; Ghinai I; Handels R; Lecomte P; Wolstenholme J;
    BMJ Open; 2018 Jun; 8(6):e020638. PubMed ID: 29884696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of the pharmacological treatment of Alzheimer's disease and vascular dementia.
    Versijpt J
    J Alzheimers Dis; 2014; 42 Suppl 3():S19-25. PubMed ID: 25061049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.
    Green C; Handels R; Gustavsson A; Wimo A; Winblad B; Sköldunger A; Jönsson L
    Alzheimers Dement; 2019 Oct; 15(10):1309-1321. PubMed ID: 31402324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and emerging treatments for Alzheimer's disease.
    Corbett A; Smith J; Ballard C
    Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predementia Alzheimer's disease. Benefits of early diagnosis].
    Viloria A
    Rev Esp Geriatr Gerontol; 2011 Oct; 46 Suppl 1():47-54. PubMed ID: 22152916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
    Gustavsson A; Cattelin F; Jönsson L
    Alzheimers Dement; 2011 Jul; 7(4):466-73. PubMed ID: 21784355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical issues in Alzheimer's disease: an overview.
    Leuzy A; Gauthier S
    Expert Rev Neurother; 2012 May; 12(5):557-67. PubMed ID: 22550984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.
    Sicras A; Rejas J; Arco S; Flores E; Ortega G; Esparcia A; Suárez A; Gordillo MJ
    Dement Geriatr Cogn Disord; 2005; 19(5-6):305-15. PubMed ID: 15785031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.